Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children
In 2012, the World Health Organisation (WHO) set out a roadmap for eliminating schistosomiasis as a public health problem by 2025. To achieve this target, preschool-aged children (PSAC; aged 6 years and below) will need to be included in schistosomiasis treatment programmes. As the global community...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529243/?tool=EBI |
id |
doaj-94b53c1b753b411ea7e5d8386d92087f |
---|---|
record_format |
Article |
spelling |
doaj-94b53c1b753b411ea7e5d8386d92087f2020-11-25T03:44:13ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352020-10-011410Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged childrenRivka M. LimMark E. J. WoolhouseTakafira MduluzaMargo Chase-ToppingDerick N. M. OsakunorLester ChitsuloFrancisca MutapiUwem Friday EkpoIn 2012, the World Health Organisation (WHO) set out a roadmap for eliminating schistosomiasis as a public health problem by 2025. To achieve this target, preschool-aged children (PSAC; aged 6 years and below) will need to be included in schistosomiasis treatment programmes. As the global community discusses the tools and approaches for treating this group, one of the main questions that remains unanswered is how to quantify infection in this age group to inform treatment strategies. The aim of this study was thus to determine whether a relationship exists between levels of schistosome infection in PSAC and school-aged children (SAC), that can be used to determine unknown schistosome infection prevalence levels in PSAC. A systematic search of publications reporting schistosomiasis prevalence in African PSAC and SAC was conducted. The search strategy was formulated using the PRISMA guidelines and SPIDER search strategy tool. The published data was subjected to regression analysis to determine if a relationship exists between infection levels in PSAC and SAC. The interaction between SAC and community treatment history was also entered in the regression model to determine if treatment history significantly affected the relationship between PSAC and SAC prevalence. The results showed that a significant positive relationship exists between infection prevalence levels in PSAC and SAC for Schistosoma mansoni (r = 0.812, df (88, 1), p = <0.0001) and S. haematobium (r = 0.786, df (53, 1), p = <0.0001). The relationship was still significant after allowing for diagnostic method, treatment history, and the African sub-region where the study was conducted (S. mansoni: F = 25.63, df (88, 9), p = <0.0001; S. haematobium: F = 10.20, df (53, 10), p = <0.0001). Using the regression equation for PSAC and SAC prevalence, over 90% of the PSAC prevalence studies were placed in the correct WHO classifications category based on the SAC levels, regardless of treatment history. The study indicated that schistosome prevalence in SAC can be extended as a proxy for infection levels in PSAC, extending on its current use in the adult population. SAC prevalence data could identify where there is a need to accelerate and facilitate the treatment of PSAC for schistosomiasis in Africa. Author summary Preschool-aged children (PSAC), i.e. aged ≤ 6 years, are not included in preventative chemotherapy programmes, currently advocated by the WHO for the treatment of schistosomiasis. This is due to the lack of a paediatric formulation of the drug of choice, praziquantel, and the current guidelines which requires diagnosis before treatment. As the global community prepares for the deployment of a new paediatric formulation of praziquantel, there is a need to find a strategy to quantify infection in this age group. In schistosome endemic areas, infection levels in school-aged children (SAC) are already used to inform infection levels in the community. Thus, we investigated the relationship between SAC and PSAC schistosome prevalence levels within the same community, to determine if data from SAC could be used to predict infection levels in PSAC. Our results show that PSAC prevalence levels are significantly correlated with SAC prevalence levels. Our findings are applicable to communities that have received preventative chemotherapy in SAC or in SAC and adults, as well as those that have not received any. Our study indicates that it is possible to extrapolate PSAC prevalence levels from SAC prevalence, and to make a treatment decision on that basis.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529243/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rivka M. Lim Mark E. J. Woolhouse Takafira Mduluza Margo Chase-Topping Derick N. M. Osakunor Lester Chitsulo Francisca Mutapi Uwem Friday Ekpo |
spellingShingle |
Rivka M. Lim Mark E. J. Woolhouse Takafira Mduluza Margo Chase-Topping Derick N. M. Osakunor Lester Chitsulo Francisca Mutapi Uwem Friday Ekpo Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children PLoS Neglected Tropical Diseases |
author_facet |
Rivka M. Lim Mark E. J. Woolhouse Takafira Mduluza Margo Chase-Topping Derick N. M. Osakunor Lester Chitsulo Francisca Mutapi Uwem Friday Ekpo |
author_sort |
Rivka M. Lim |
title |
Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children |
title_short |
Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children |
title_full |
Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children |
title_fullStr |
Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children |
title_full_unstemmed |
Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children |
title_sort |
investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Neglected Tropical Diseases |
issn |
1935-2727 1935-2735 |
publishDate |
2020-10-01 |
description |
In 2012, the World Health Organisation (WHO) set out a roadmap for eliminating schistosomiasis as a public health problem by 2025. To achieve this target, preschool-aged children (PSAC; aged 6 years and below) will need to be included in schistosomiasis treatment programmes. As the global community discusses the tools and approaches for treating this group, one of the main questions that remains unanswered is how to quantify infection in this age group to inform treatment strategies. The aim of this study was thus to determine whether a relationship exists between levels of schistosome infection in PSAC and school-aged children (SAC), that can be used to determine unknown schistosome infection prevalence levels in PSAC. A systematic search of publications reporting schistosomiasis prevalence in African PSAC and SAC was conducted. The search strategy was formulated using the PRISMA guidelines and SPIDER search strategy tool. The published data was subjected to regression analysis to determine if a relationship exists between infection levels in PSAC and SAC. The interaction between SAC and community treatment history was also entered in the regression model to determine if treatment history significantly affected the relationship between PSAC and SAC prevalence. The results showed that a significant positive relationship exists between infection prevalence levels in PSAC and SAC for Schistosoma mansoni (r = 0.812, df (88, 1), p = <0.0001) and S. haematobium (r = 0.786, df (53, 1), p = <0.0001). The relationship was still significant after allowing for diagnostic method, treatment history, and the African sub-region where the study was conducted (S. mansoni: F = 25.63, df (88, 9), p = <0.0001; S. haematobium: F = 10.20, df (53, 10), p = <0.0001). Using the regression equation for PSAC and SAC prevalence, over 90% of the PSAC prevalence studies were placed in the correct WHO classifications category based on the SAC levels, regardless of treatment history. The study indicated that schistosome prevalence in SAC can be extended as a proxy for infection levels in PSAC, extending on its current use in the adult population. SAC prevalence data could identify where there is a need to accelerate and facilitate the treatment of PSAC for schistosomiasis in Africa. Author summary Preschool-aged children (PSAC), i.e. aged ≤ 6 years, are not included in preventative chemotherapy programmes, currently advocated by the WHO for the treatment of schistosomiasis. This is due to the lack of a paediatric formulation of the drug of choice, praziquantel, and the current guidelines which requires diagnosis before treatment. As the global community prepares for the deployment of a new paediatric formulation of praziquantel, there is a need to find a strategy to quantify infection in this age group. In schistosome endemic areas, infection levels in school-aged children (SAC) are already used to inform infection levels in the community. Thus, we investigated the relationship between SAC and PSAC schistosome prevalence levels within the same community, to determine if data from SAC could be used to predict infection levels in PSAC. Our results show that PSAC prevalence levels are significantly correlated with SAC prevalence levels. Our findings are applicable to communities that have received preventative chemotherapy in SAC or in SAC and adults, as well as those that have not received any. Our study indicates that it is possible to extrapolate PSAC prevalence levels from SAC prevalence, and to make a treatment decision on that basis. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529243/?tool=EBI |
work_keys_str_mv |
AT rivkamlim investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT markejwoolhouse investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT takafiramduluza investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT margochasetopping investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT dericknmosakunor investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT lesterchitsulo investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT franciscamutapi investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren AT uwemfridayekpo investigatingastrategyforquantifyingschistosomeinfectionlevelsinpreschoolagedchildrenusingprevalencedatafromschoolagedchildren |
_version_ |
1724515479737860096 |